Search

ASSELTA, ROSANNA, open, The main goal of this PhD project was to leverage the great body of genetic knowledge generated by high-throughput DNA sequencing to better characterize the genetic architecture of immune diseases, with a main focus on Primary Biliary Cholangitis (PBC). Our work has employed established statistical methods such as meta-analysis as well as novel data mining tools, such as packages dedicated to the study of chromosome X (chrX) and Machine Learning (ML) softwares. In addition, we have also applied established computational methods and ML tools to shed light on the evolutionary history of variants associated with immune-mediated traits. More specifically, the meta-analysis of previous Genome-Wide Association Studies (GWAS) in PBC has identified additional risk loci and, by means of functional annotation of credible causal variants and multi-omic analysis, has produced a list of candidate genes together with several drugs that are potentially suitable for re-purposing to PBC. The extensive analysis of chrX has identified several suggestive new loci associated with PBC located on this chromosome. The major finding of the X-Wide Association Study (XWAS) approach has been the identification of a genome-wide significantly associated locus characterized by the presence of different genes and of a superenhancer possibly involved in their co-regulation, as well as in the regulation of FOXP3 (which is located in the same TAD). Based on the new set of variants identified in the international meta-analysis, we have generated a novel Polygenic Risk Score (PRS) that has been incorporated in a new integrative risk model. This model, that has included 22 non-HLA variants, one HLA variant and sex, is accurate (Area Under the Curve (AUC) 0.83 and 0.81 in the two cohorts under study) and well calibrated. The PRS has pinpointed a subgroup of subjects at strikingly higher risk (OR ~ 14) of developing the disease that should be the target of tailored follow-up strategies. Prospective studie, Lo scopo principale di questo lavoro di tesi di dottorato è stato l'utilizzo dell'ampio materiale genetico disponibile a seguito del sequenziamento del DNA per migliorare la caratterizzazione dell'architettura genetica delle malattie autoimmuni, con un focus specifico sulla Colangite Biliare Primitiva. Il nostro lavoro ha utilizzato metodi statistici "classici" come la meta-analisi e metodi di analisi dati nuovi, come pacchetti dedicati allo studio del cromosoma X e software di Machine Learning. Inoltre abbiamo applicate tecniche di biologia evoluzionistica computazionale per studiare la storia evolutiva delle varianti associate alla immunità., 0, open, Gerussi, A

Lo scopo principale di questo lavoro di tesi di dottorato è stato l'utilizzo dell'ampio materiale genetico disponibile a seguito del sequenziamento del DNA per migliorare la caratterizzazione dell'architettura genetica delle malattie autoimmuni, con un focus specifico sulla Colangite Biliare Primitiva. Il nostro lavoro ha utilizzato metodi statistici "classici" come la meta-analisi e metodi di analisi dati nuovi, come pacchetti dedicati allo studio del cromosoma X e software di Machine Learning. Inoltre abbiamo applicate tecniche di biologia evoluzionistica computazionale per studiare la storia evolutiva delle varianti associate alla immunità., The main goal of this PhD project was to leverage the great body of genetic knowledge generated by high-throughput DNA sequencing to better characterize the genetic architecture of immune diseases, with a main focus on Primary Biliary Cholangitis (PBC). Our work has employed established statistical methods such as meta-analysis as well as novel data mining tools, such as packages dedicated to the study of chromosome X (chrX) and Machine Learning (ML) softwares. In addition, we have also applied established computational methods and ML tools to shed light on the evolutionary history of variants associated with immune-mediated traits. More specifically, the meta-analysis of previous Genome-Wide Association Studies (GWAS) in PBC has identified additional risk loci and, by means of functional annotation of credible causal variants and multi-omic analysis, has produced a list of candidate genes together with several drugs that are potentially suitable for re-purposing to PBC. The extensive analysis of chrX has identified several suggestive new loci associated with PBC located on this chromosome. The major finding of the X-Wide Association Study (XWAS) approach has been the identification of a genome-wide significantly associated locus characterized by the presence of different genes and of a superenhancer possibly involved in their co-regulation, as well as in the regulation of FOXP3 (which is located in the same TAD). Based on the new set of variants identified in the international meta-analysis, we have generated a novel Polygenic Risk Score (PRS) that has been incorporated in a new integrative risk model. This model, that has included 22 non-HLA variants, one HLA variant and sex, is accurate (Area Under the Curve (AUC) 0.83 and 0.81 in the two cohorts under study) and well calibrated. The PRS has pinpointed a subgroup of subjects at strikingly higher risk (OR ~ 14) of developing the disease that should be the target of tailored follow-up strategies. Prospective studie